Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia

NCT04901676 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

612

Enrollment

OTHER

Sponsor class

Stopped Pending DSMB evaluation

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Leronlimab
DRUG: Placebo

Sponsor

Hospital Israelita Albert Einstein

Collaborators

[object Object]